Reliable updates on the ongoing COVID-19 Outbreak
You can find thre reliable sources of information regarding the COVID-19 outbreake below:
The WHO dashboard - provides and up to date situational analysis, updated daily.
https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd
The LitCovid hub – a curated literature hub for tracking up-to-date scientific information about COVID-19. This site is the most comprehensive resource on the pandemic, giving access to research articles in PubMed categorised by different research topics - General Info, mechanism, transmission, treatment, case reports and epidemic forecasting. The content is updated daily and as this morning there were are 950 papers published in the last 2,5 months.
https://www.ncbi.nlm.nih.gov/research/coronavirus/
The COVID-19 Global Cases dashboard - provides daily updated (per country - total cases, recovered, deaths), hosted by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Dr Nesri Padayatchi (EDCTP Senior Fellow 2011) - a leading expert in MDR-TB - Awarded SAMRC Silver Scientific Achievement Award!
EDCTP alumnus - a well- known research clinician, epidemiologist, academic and scientist in multidrug resistance tuberculosis (MDR-TB) was recognised by the South African Medical Research Council (SAMRC) for her research excellence in the management of patients with MDR and XDR TB. Dr Nesri Padayatchi, a scientist and Deputy Director at the Centre for the AIDS Programme of Research in South Africa (CAPRISA), received the SAMRC 2018 Silver Scientific Achievement Award, a medal, at the SAMRC Scientific Merit awards in last year.
“SAMRC recognises and congratulates you as an outstanding South African scientist who has contributed to raising the profile of science in South Africa,” said Dr Mike Sathekge, chairperson of the SAMRC Board.
Professor Nesri Padayatchi, MBChB, DCH(Paediatrics), DTM&H (Tropical Medicine), DPH(Public Health), DHSM (Health Management) MS(Epi), is an honorary Associate Professor in Public Health and Nursing, in the College of Health Sciences at the University of KwaZulu-Natal in Durban, South Africa.
She has more than 30 years clinical and research experience in the management of TB and related problems. Respected as an authority on the treatment of multi-drug resistant tuberculosis, her experience extends to the design and implementation of several self-initiated TB-HIV clinical trials as the Principal and/or co-investigator of the studiesShe serves as the South African Principal Investigator for the Columbia University-Southern African Fogarty AIDS International Training and Research Programme since 2009. She serves on the South African National Advisory Board for MDR –TB since 2010 to date and on the KwaZulu Natal MDR-TB technical advisory committee since 2013.
Her biggest scientific contribution has been as a co-investigator in the SAPiT and STRIDE (A5221) studies which changed not only South African guidelines for the management of patients with TB-HIV coinfection, but also WHO and DHHS guidelines.
She has participated as the Principal Investigator in the Centres for Disease Control and Prevention TB Trials Consortium and was the CAPRISA Principal Investigator for the ACTG studies from 2006-2013. She has published several scientific papers on TB-HIV in high impact journals and is a member of the Academy of Science of South Africa.
Padayatchi serves on several scientific bodies that include, the International Union against TB and Lung Diseases (IUATLD) Ethics Advisory Group, the Board of the South African HIV Clinicians society, the South African National and Provincial Advisory Boards for MDR –TB.
“I am honoured and humbled to be recognised by the South African Research Medical Council and my peers,” said Padayatchi. “TB remains the leading cause of death in South Africa and MDR-TB, in particular, threatens the gains made in HIV. MDR TB remains a serious global threat particularly in impoverished communities constrained countries.”
The Union: Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health
Submissions Open for Late-Breaker Sessions on TB, COVID-19 and Lung Health
The 52nd Union World Conference on Lung Health is pleased to announce that submissions for Late-Breaker Sessions are open from 15 July-12 August 2021. Submit now.
In keeping with the spirit of a late-breaker session, we ask that only new, innovative and significant findings of broad interest that have occurred after 12 May, or for which information has just become available, be submitted for the late-breaker sessions.
The following three late-breaker sessions are slated for the Conference that will take place from 19-22 October 2021:
THE UNION LATE-BREAKER SESSION ON COVID-19
All aspects of SARS-CoV-2 and Covid-19-related lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, clinical trials for vaccines or therapeutics, to operational research in adults and children.
This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with the online audience.
THE UNION/CDC LATE-BREAKER SESSION ON TB
The 52nd Union World Conference on Lung Health and the United States Centers for Disease Control and Prevention (CDC) are pleased to announce a late-breaker session related to tuberculosis (TB).
This late-breaker session includes all aspects of TB prevention, diagnosis, and treatment research (including basic and clinical science, epidemiology, social, behavioural, and health care delivery). Given the global COVID-19 pandemic, we will also consider select presentations that explore the intersection of COVID-19 and TB prevention and programmatic implementation. It will consist of 7 pre-recorded oral presentations of 8 minutes each and live Q&A at the end of the session. The session is scheduled on 22 October 2021.
THE UNION STUDENT LATE-BREAKER SESSION ON LUNG HEALTH
The 52nd Union World Conference on Lung Health is pleased to announce the Union student late-breaker session focusing on lung health and sponsored by the Research Institute of Tuberculosis of the Japan Anti-Tuberculosis Association (RIT/JATA).
All aspects of lung health are welcomed for presentation during the late-breaker session, from basic science in immunology and vaccines, to operational research in tuberculosis (TB), Chronic Obstructive Pulmonary Disease (COPD), pneumonia, and other lung health issues in adults and children. This session will consist of up to seven pre-recorded oral presentations of 8 minutes each, followed by live Q&A with online audience.
Individuals submitting an abstract must be currently enrolled as a student in a university programme at undergraduate, graduate, or doctoral level either full- or part-time.
DETAILS
All abstracts must follow the abstract submission guidelines
For more information and details on sponsorship for late-breaker sessions: https://theunion.org/late-breaker-sessions
For any further queries, email scientific@theunion.org
Submit now!
CARNEGIE AFRICAN DIASPORA FELLOWSHIP PROGRAM - APPLICATIONS DUE MONDAY 4 MARCH 2024
The Carnegie African Diaspora Fellowship Program (CADFP) is a fellowship program for African institutions in Ghana, Kenya, Nigeria, South Africa, Tanzania, Uganda and member institutions of the African Research Universities Alliance (ARUA) and partner universities with the Consortium for Advanced Research Training in Africa (CARTA) to host an African-born scholar to work on projects in research collaboration, graduate student teaching/mentoring and curriculum co-development. The application process has two parts.
The Carnegie African Diaspora Fellowship Program is a fellowship program that supports educational projects in African higher education institutions. This is an opportunity for African-born scholars living in the U.S. or Canada to travel to Africa to work on a project in one of the following: Innovations in curriculum co-development, new approaches and methods to graduate mentoring and training, and impactful research collaboration and capacity strengthening.
Applications due Monday, Mar. 4, 2024.